HealthcareThinly traded Chembio Diagnostics (CEMI +4.2%) promptly erases a 1.6% decline after SA Pro...Jun. 28, 2013 3:10 PM ETChembio Diagnostics, Inc. (CEMI) StockCEMIBy: Colin Lokey, SA News EditorThinly traded Chembio Diagnostics (CEMI +4.2%) promptly erases a 1.6% decline after SA Pro contributor Paul Nouri's article comes out of embargo. Nouri says the company could earn $0.45/share by 2015.Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgCEMI--Chembio Diagnostics, Inc.Trending AnalysisTrending News